60 Degrees Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Washington, DC
SXTP chart
What traders are saying about $SXTP
Latest posts60 Degrees Pharmaceuticals, Inc. news
- Form 8K 60 Degrees Pharmaceuticals Inc For: 27 October By Investing.com
Investing.com Canada ·
- 60 Degrees Pharmaceuticals Reports Positive Results in Five Babesiosis Study Patients
TradingView ·
- 60 Degrees Pharmaceuticals Announces Clinical Improvement and Negative PCR Results in All Completed Expanded Access Babesiosis Study Patients
Yahoo Finance ·
- All five patients reported improvement; a sensitive post-treatment test found no parasite in four.
Stock Titan ·
- 60 Degrees Pharmaceuticals, Inc. Estimates – NASDAQ:SXTP
TradingView ·
- Form 8K 60 Degrees Pharmaceuticals Inc For: 23 October By Investing.com
Investing.com Canada ·
- 60 Degrees Pharmaceuticals Outlines Tafenoquine Progress and Potential 2027 FDA Filing
TradingView ·
- 60 Degrees Pharmaceuticals Sets January 2027 Babesiosis Data Readout and Plans FDA Pre-sNDA Meeting
investorshub.advfn.com ·
- 60 Degrees Pharmaceuticals Plans January 2027 Hospitalized Babesiosis Data Readout; Will Seek Pre-sNDA Meeting with FDA
Yahoo Finance ·
- 60 Degrees Pharmaceuticals and Exyn Technologies Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
Yahoo Finance ·
- 60 Degrees Pharmaceuticals Announces Date for Hospitalized Babesiosis Study Interim Data Release and Key Opinion Leader Webinar
Yahoo Finance ·
- 60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results
Yahoo Finance ·
60 Degrees Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $1.0M | $607,574 | $253,573 | $223,208 |
| Net income | -$7.4M | -$7.9M | -$3.8M | -$6.2M |
| Diluted EPS | $-11.73 | $-74.17 | $-59.18 | $-2.61 |
| Total assets (year end) | $5.4M | $5.8M | $7.8M | $1.3M |
| Cash and equivalents (year end) | $1.5M | $1.7M | $2.1M | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About 60 Degrees Pharmaceuticals, Inc.
- Ticker
- SXTP (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Washington, DC
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1946563
Frequently asked questions
What exchange is 60 Degrees Pharmaceuticals, Inc. listed on?
60 Degrees Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol SXTP.
What industry is 60 Degrees Pharmaceuticals, Inc. in?
60 Degrees Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is 60 Degrees Pharmaceuticals, Inc. headquartered?
60 Degrees Pharmaceuticals, Inc.'s business address on file with the SEC is in Washington, DC.
When does 60 Degrees Pharmaceuticals, Inc.'s fiscal year end?
60 Degrees Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did 60 Degrees Pharmaceuticals, Inc. report?
60 Degrees Pharmaceuticals, Inc. reported $1.0M in revenue for calendar year 2025, according to its SEC filings.